Cabaletta Bio (CABA) Accumulated Depreciation & Amortization (2019 - 2025)
Cabaletta Bio's quarterly Accumulated Depreciation & Amortization came in at $7.2 million in Q4 2025, up 29.89% year-on-year from $5.5 million in Q4 2024, and up 29.89% quarter-over-quarter from $5.5 million in Q4 2024.
Cabaletta Bio has reported Accumulated Depreciation & Amortization for 7 years, with the latest figure at $7.2 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 29.89% year-over-year to $7.2 million; the trailing twelve-month figure through Dec 2025 stood at $7.2 million (up 29.89% YoY), and the FY2025 full-year result was $7.2 million, up 29.89% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $7.2 million, up from $5.5 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $7.2 million in Q4 2025, with the low at $1.2 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $4.0 million, with a median of $3.8 million recorded in 2023.
- Year-over-year, Accumulated Depreciation & Amortization jumped 160.04% in 2021 and advanced 29.89% in 2025.
- Tracing CABA's Accumulated Depreciation & Amortization over 5 years: stood at $1.2 million in 2021, then soared by 98.91% to $2.4 million in 2022, then jumped by 60.19% to $3.8 million in 2023, then jumped by 45.09% to $5.5 million in 2024, then gained by 29.89% to $7.2 million in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $7.2 million (Q4 2025), $5.5 million (Q4 2024), and $3.8 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.15 Mn |
| Dec 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2020 | 458,000.00 |
| Dec 31, 2020 | 458,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Dec 31, 2019 | 104,000.00 |